CIK: 1543792 - Address: C/O Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1121-214203913134
S%wins5050000017

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/6/22 19:07
12/2/22
HALOHalozyme Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagPosard Matthew L.CADS.m-1,70756.890-30-22105D
12/1/21 21:41
11/30/21
NAUTNautilus Biotechnology, Inc.DEElectrLabEqLaboratory Analytical InstrumPosard Matthew L.WADP.m2264.5105050150D
2/19/21 18:13
2/17/21
TLISTalis Biomedical CorpDEElectrLabEqLaboratory Analytical InstrumPosard Matthew L.CADP1,00016.00063New63D
1/13/21 16:21
1/11/21
DMTKDermtech, Inc.DEHealthHealthMedical LaboratoriesPosard Matthew L.CADP1,00029.500346487D
5/1/20 16:24
4/29/20
DMTKDermtech, Inc.DEHealthHealthMedical LaboratoriesPosard Matthew L.CADM.d676.940102845D
1/3/20 16:10
12/31/19
DMTKDermtech, Inc.HealthHealthMedical LaboratoriesPosard Matthew L.CADM.d00.0001612129D
5/30/13 18:29
5/30/13
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumPosard Matthew L.CAOSVP,GMM.d10537.043331031D-2643945236-10-2-45738124
5/30/13 18:29
5/30/13
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumPosard Matthew L.CAOSVP,GMS.d-20170.8033-3-831D-2643945236-10-2-45738124
4/15/13 20:06
4/11/13
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumPosard Matthew L.CAOSVP,GMM.d1,46930.45334831D-15101181197441233339138
4/15/13 20:06
4/11/13
ILMNIllumina IncDEElectrLabEqLaboratory Analytical InstrumPosard Matthew L.CAOSVP,GMS.d-2,79557.9533-48-6131D-15101181197441233339138

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact